7/1/2014 8:52:56 AM
GAINESVILLE, Fla., July 1, 2014 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene therapies for the treatment of rare eye diseases, today announced the appointment of Matthew Feinsod, MD, to the position of Product Development Officer.
Help employers find you! Check out all the jobs and post your resume.
comments powered by